EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting the Notch-Furin axis with 2-hydroxyoleic acid: a key mechanism in glioblastoma therapy

Raquel Rodríguez-Lorca iD, Ramón Román, Roberto Beteta-Göbel, Manuel Torres, Victoria Lladó, Pablo V Escribá, Paula Fernández-García

Cellular Oncology · 2025

DOI: 10.1007/s13402-024-00995-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2025. Verfasst von Raquel Rodríguez-Lorca und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Laboratory of Molecular Cell Biomedicine, University of the Balearic Islands, Palma de Mallorca, 07122, Spain. raquel.rodrigue…. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Receptors, Notch, Receptor, Notch2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitat de Les Illes Balears.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Glioblastomas (GBMs) are highly treatment-resistant and aggressive brain tumors. 2OHOA, which is currently running a phase IIB/III clinical trial for newly diagnosed GBM patients, was developed in the context of melitherapy. This therapy focuses on the regulation of the membrane’s structure and organization with the consequent modulation of certain cell signals to revert the pathological state in several disorders. Notch signaling has been associated with tumorigenesis and cell survival, potentially driving the pathogenesis of GBM. The current study aims to determine whether 2OHOA modulates the Notch pathway as part of its antitumoral mechanism.

Methods

2OHOA’s effect was evaluated on different components of the pathway by Western blot, Q-PCR, and confocal microscopy. Notch receptor processing was analyzed by subcellular fractionation and colocalization studies. Furin activity was evaluated under cleavage of its substrate by fluorescence assays and its binding affinity to 2OHOA was determined by surface plasmon resonance.

Results

We found that 2OHOA inhibits Notch2 and Notch3 signaling by dual mechanism. Notch2 inhibition is unleashed by impairment of its processing through the inactivation of furin activity by physical association. Instead, Notch3 is transcriptionally downregulated leading to a lower activation of the pathway. Moreover, we also found that HES1 overexpression highlighted the relevance of this pathway in the 2OHOA pharmacological efficacy.

Conclusion

These findings report that the inhibition of Notch signaling by 2OHOA plays a role in its anti-tumoral activity, an effect that may be driven through direct inhibition of furin, characterizing a novel target of this bioactive lipid to treat GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsReceptors, NotchReceptor, Notch2HumansSignal TransductionCell Line, TumorReceptor, Notch3Gene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

2OHOAFurinGBMHes1MelitherapyNotch

Substanzen

Receptors, NotchReceptor, Notch3Receptor, Notch2NOTCH3 protein, human

Autor:innen und Institutionen

  • Department of Biology, Laboratory of Molecular Cell Biomedicine, University of the Balearic Islands, Palma de Mallorca, 07122, Spain. raquel.rodriguez@uib.es.
  • R&D Department, Laminar Pharmaceuticals, C/Isaac Newton, Palma de Mallorca, 07121, Spain. raquel.rodriguez@uib.es.
  • Department of Biology, Laboratory of Molecular Cell Biomedicine, University of the Balearic Islands, Palma de Mallorca, 07122, Spain.
  • R&D Department, Laminar Pharmaceuticals, C/Isaac Newton, Palma de Mallorca, 07121, Spain.
  • Department of Biology, Laboratory of Molecular Cell Biomedicine, University of the Balearic Islands, Palma de Mallorca, 07122, Spain. pablo.escriba@uib.es.
  • R&D Department, Laminar Pharmaceuticals, C/Isaac Newton, Palma de Mallorca, 07121, Spain. pablo.escriba@uib.es.

ORCID-Profile: Raquel Rodríguez-Lorca

Förderung

  • Universitat de Les Illes Balears

Zitieren

APA

Rodríguez-Lorca, R., Román, R., Beteta-Göbel, R., Torres, M., Lladó, V., Escribá, P. V., & Fernández-García, P. (2025). Targeting the Notch-Furin axis with 2-hydroxyoleic acid: a key mechanism in glioblastoma therapy. Cellular Oncology. https://doi.org/10.1007/s13402-024-00995-x

Vancouver

Rodríguez-Lorca R, Román R, Beteta-Göbel R, Torres M, Lladó V, Escribá PV, et al. Targeting the Notch-Furin axis with 2-hydroxyoleic acid: a key mechanism in glioblastoma therapy. Cellular Oncology. 2025. doi:10.1007/s13402-024-00995-x

BibTeX
@article{RodrguezLorca2025,
  author = {Rodríguez-Lorca, Raquel and Román, Ramón and Beteta-Göbel, Roberto and Torres, Manuel and Lladó, Victoria and Escribá, Pablo V and Fernández-García, Paula},
  title = {Targeting the Notch-Furin axis with 2-hydroxyoleic acid: a key mechanism in glioblastoma therapy},
  journal = {Cellular Oncology},
  year = {2025},
  doi = {10.1007/s13402-024-00995-x}
}
Kostenlos starten →